AHS Cancer Control Alberta
190
24
31
77
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
27.4%
52 terminated/withdrawn out of 190 trials
59.7%
-26.8% vs industry average
4%
8 trials in Phase 3/4
0%
0 of 77 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (190)
Steroid Sparing in Immune Related Hepatitis (irH)
Role: lead
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
Role: lead
Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
Role: lead
Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients
Role: lead
COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer
Role: lead
Loratadine for the Prevention of G-CSF-related Bone Pain
Role: lead
A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys
Role: lead
Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer
Role: lead
mHealth Physical Activity Intervention for Young Cancer Survivors
Role: lead
Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Role: lead
Study of Niacin in Glioblastoma
Role: lead
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
Role: lead
Chemoradiotherapy for Advanced Esophageal Cancer
Role: lead
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
Role: lead
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
Role: lead
This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer
Role: lead
Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer
Role: lead
A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
Role: lead
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma
Role: lead
Pre- Versus Post-operative SRS for Resectable Brain Metastases
Role: lead